Sialyl Lewisa expression as a predictor of the prognosis of colon carcinoma patients in a prospective randomized clinical trial

Japanese Journal of Clinical Oncology

Volumn 34, Issue 10, 2004, Pages 588-593

  Matsui, Takanori ^a   Kojima, Hiroshi ^a   Suzuki, Harumi ^a   Hamajima, Hiroshi ^a   Nakazato, Hiroaki ^b   Ito, Katsuki ^c   Nakao, Akimasa ^c   Sakamoto, Junichi ^d  

^a AICHI PREFECTURAL UNIVERSITY   (Japan)

^b Yokoyama Gastrointestinal Hospital   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Colon cancer; Prognosis; Prospective randomized clinical trial; Sialyl Lewisa

Indexed keywords

FLUOROURACIL; KRESTIN; SIALYL LEWIS X ANTIGEN; CD15 ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; CLINICAL TRIAL; COLON CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TUMOR CELL; ADJUVANT CHEMOTHERAPY; BIOSYNTHESIS; BLOOD; BLOOD GROUP LEWIS SYSTEM; COLON TUMOR; IMMUNOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL;

ANTIGENS, CD15; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOCHEMISTRY; LEWIS BLOOD-GROUP SYSTEM; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 16644364450     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/hyh110     Document Type: Article

References (16)

1. Dabelsteen E. Cell surface carbohydrates as prognostic markers in human carcinomas. J Pathol 1996;179:358-69.
2. Takada A, Ohmori K, Yoneda T, Tsuyuoka K, Hasegawa A, Kiso M, et al. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res 1993;53:354-61.
3. Tei K, Kawakami-Kimura N, Taguchi O, Kumamoto K, Higashiyama S, Taniguchi N, et al. Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats. Cancer Res 2002;62:6289-96.
4. Nakazato H et al., Proc ASCO 18: abs. 245, 1999.
5. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet 1979;5:957-71.
6. Ougolkov AV, Yamashita K, Mai M, Minamoto T. Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer. Gastroenterology 2002; 122:60-71.
7. Sakamoto J, Hamashima H, Suzuki H, Ito K, Mai M, Saji S, et al. Thymidylate synthase expression as a predictor of the prognosis of curatively resected colon carcinoma in patients registered in an adjuvant immunochemotherapy clinical trial. Oncol Rep 2003;10: 1081-90.
8. Shimono R, Mori M. Akazawa K, Adachi Y. Sugimachi K. Immunohistochemical expression of carbohydrate antigen 19-9 in colorectal carcinoma. Am J Gastroenterol 1994;89:101-5.
9. Nakayama T, Watanabe M, Katsumata T, Teramoto T, Kitajima M. Expression of sialyl Lewis A as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer 1995;75:2051-6.
10. Ikeda Y, Mori M, Kajiyama K, Haraguchi Y. Sasaki O, Sugimachi K. Immunohistochemical expression of sialyl Tn, sialyl Lewis a, sialyl Lewis a-b-, and sialyl LewisX in primary tumor and metastatic lymph nodes in human gastric cancer. J Surg Oncol 1996;62:171-6.
11. Nakagoe T, Fukushima K, Nanashima A, Sawai T, Tsuji T, Jibiki M, et al. Expression of Lewis a, sialyl Lewis a, LewisX and sialyl LewisX antigens as prognostic factors in patients with colorectal cancer. Can J Gastroenterol 2000:14:753-60.
12. Asai S, Watanabe T, Sakamoto J, Kiriyama K, Ito K, Akiyama S, et al. Expression and prognostic indicators of type 1 and type 2 Lewis blood group antigens in colorectal cancers. Nippon Geka Gakkai Zasshi 1994:95:753-62.
13. Tsumatori G, Ozeki Y, Takagi K, Ogata T, Tanaka S. Relation between the serum E-selectin level and the survival rate of patients with resected non-small cell lung cancers. Jpn J Cancer Res 1999;90:301-7.
14. Arends JW, Wiggers T, Verstijnen C. Hilgers J. Bosman FT. Gastrointestinal cancer-associated antigen (GICA) immunoreactivity in colorectal carcinoma in relation to patient survival. Int J Cancer 1984;34:193-6.
15. Walker RA, Day SJ. Expression of the antigen detected by the monoclonal antibody CA19-9 in human breast tissues. Virchows Arch A Pathol Anat Histopathol 1986:409:375-83.
16. Meta-analysis group of the Japanese Society for Cancer of the Colon and Rectum and the Meta-analysis Group in Cancer. Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials. J Clin Oncol 2004;22:484-92.